Consistent with this, epigenetic silencing of PRSS3 was found in several cancer types (32–35), and our previous study showed intragenic DNA methylation within the extended promoter region contributing to PRSS3/TRY-4 downregulation in HCC (36). This evidence concerns the gene PRSS3 and hepatocellular carcinoma.